Choroidal Response to Anti-VEGF Therapy in Subgroups Classified by Preexisting Ophthalmic or Systemic Condition
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ahn, Seong Joon | - |
dc.contributor.author | Park, Kyu Hyung | - |
dc.contributor.author | Woo, Se Joon | - |
dc.date.accessioned | 2022-07-15T19:57:06Z | - |
dc.date.available | 2022-07-15T19:57:06Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2015-12 | - |
dc.identifier.issn | 0146-0404 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/155691 | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ASSOC RESEARCH VISION OPHTHALMOLOGY INC | - |
dc.title | Choroidal Response to Anti-VEGF Therapy in Subgroups Classified by Preexisting Ophthalmic or Systemic Condition | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Ahn, Seong Joon | - |
dc.identifier.doi | 10.1167/iovs.15-18634 | - |
dc.identifier.scopusid | 2-s2.0-84952919496 | - |
dc.identifier.wosid | 000368243800093 | - |
dc.identifier.bibliographicCitation | INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, v.56, no.13, pp.8364 - 8364 | - |
dc.relation.isPartOf | INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | - |
dc.citation.title | INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | - |
dc.citation.volume | 56 | - |
dc.citation.number | 13 | - |
dc.citation.startPage | 8364 | - |
dc.citation.endPage | 8364 | - |
dc.type.rims | ART | - |
dc.type.docType | Letter | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Ophthalmology | - |
dc.subject.keywordPlus | vasculotropin inhibitor | - |
dc.subject.keywordPlus | angiogenesis inhibitor | - |
dc.subject.keywordPlus | bevacizumab | - |
dc.subject.keywordPlus | ranibizumab | - |
dc.subject.keywordPlus | vasculotropin A | - |
dc.subject.keywordPlus | choroid disease | - |
dc.subject.keywordPlus | choroidal thickness | - |
dc.subject.keywordPlus | diabetes mellitus | - |
dc.subject.keywordPlus | eye disease | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | hypercholesterolemia | - |
dc.subject.keywordPlus | hypertension | - |
dc.subject.keywordPlus | Letter | - |
dc.subject.keywordPlus | priority journal | - |
dc.subject.keywordPlus | retrolental fibroplasia | - |
dc.subject.keywordPlus | sensory system parameters | - |
dc.subject.keywordPlus | subretinal neovascularization | - |
dc.subject.keywordPlus | treatment response | - |
dc.subject.keywordPlus | antagonists and inhibitors | - |
dc.subject.keywordPlus | choroid | - |
dc.subject.keywordPlus | Choroidal Neovascularization | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | Myopia, Degenerative | - |
dc.subject.keywordPlus | pathology | - |
dc.identifier.url | https://iovs.arvojournals.org/article.aspx?articleid=2480514 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.